Research & Development
The promise of tomorrow’s breakthrough products drives our unwavering commitment to innovation. Our research and development team is focused on advancing veterinary medicine in key therapeutic areas.
The development of our leading scientific advances, treatments and solutions is led by the industry’s foremost researchers, working in state-of-the-art facilities around the world.
We need to invest heavily in research today if we are to see scientific advances tomorrow. Our robust portfolio of veterinary medicines and vaccines reflects our unwavering commitment to research and development.
We have hundreds of ongoing projects focused on everything from combating parasites and infections to improving animal health and performance.
Our research includes the vital field of biologics, where we’re focused on using new technologies that will address a range of diseases. This includes zoonotic diseases (diseases that affect both humans and animals).
Our company has an exceptional track record of discovering and developing first- and best-in-class opportunities in small molecules, vaccine technologies and biotechnologies, such as monoclonal antibodies.
We conduct our critical research with multiple research sites focused on both vaccine (biological) and pharmaceutical research. We also maintain research operations focused on local issues and respond quickly to changing market needs.
In today’s competitive, ever-changing business environment, no company can afford to do it alone. We achieve our ambitious goals through internal discovery efforts and co-innovation partnerships with pharmaceutical and crop science companies as well as academic institutions. Furthermore, we invest in adjacent technology opportunities through a dedicated innovation fund.
We also collaborate closely with our colleagues in Merck Human Health to share best practices
and leverage the power of our combined research effort.